Heart

Friend or foe? Middle-aged women are confronted by a bewildering array of medication and advice

HRT: The debate goes on

Since as early as the 1940s, women of a certain age have had the option of hormone replacement therapy (HRT)…

Magic bullet or massive missfire?

Forty years ago Henry Gadsden, chief executive of the drug company Merck, expressed his frustration that the potential market for…